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Abstract: The stromal cell-derived factor-1
(SDF-1)/CXC chemokine receptor 4 (CXCR4) sig-
naling pathway is thought to play an important role
in the induction of neutrophil mobilization from
the bone marrow in response to granulocyte-col-
ony stimulating factor (G-CSF) treatment. CXCR4
belongs to the family of G protein-coupled recep-
tors. Multiple members of this receptor family are
desensitized by agonist-induced G protein-coupled
receptor kinase (GRK)-mediated phosphorylation.
Here, we demonstrate that in vitro SDF-1-induced
chemotaxis of bone marrow-derived neutrophils
from GRK6-deficient mice is significantly en-
hanced and that desensitization of the calcium re-
sponse to SDF-1 is impaired in GRK6/ neutro-
phils. CXCR4 activation by SDF-1 provides a key
retention signal for hematopoietic cells in the bone
marrow. It is interesting that we observed that in
the absence of GRK6, the G-CSF-induced increase
in circulating neutrophils is profoundly impaired.
Three days after injection of pegylated-G-CSF, sig-
nificantly lower numbers of circulating neutrophils
were observed in GRK6/ as compared with
wild-type (WT) mice. In addition, early/acute neu-
trophil mobilization in response to G-CSF (3 h after
treatment) was also impaired in GRK6/ mice.
However, blood neutrophil levels in untreated
GRK6/ and WT mice were not different. More-
over, the percentage of neutrophils in the bone
marrow after G-CSF treatment was increased to
the same extent in WT and GRK6/ mice, indi-
cating that neutrophil production is normal in the
absence of GRK6. However, the increased chemo-
tactic sensitivity of GRK6/ neutrophils to
SDF-1 was retained after G-CSF treatment. In view
of these data, we suggest that the impaired G-CSF-
induced neutrophil mobilization in the absence of
GRK6 may be a result of enhanced CXCR4-medi-
ated retention of PMN in the bone marrow. J.
Leukoc. Biol. 75: 698–704; 2004.
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INTRODUCTION
Chemokines constitute the largest family of cytokines, with
over 50 distinct members and at least 16 different receptors
known so far. Although originally characterized as inflamma-
tory mediators, it is now becoming clear that the chemokine
system regulates multiple physiological and pathological pro-
cesses, including tumorigenesis, hematopoiesis, and fetal de-
velopment [1–4]. Stromal cell-derived factor-1 [SDF-1; CXC
chemokine ligand 12 (CXCL12)] and its receptor CXC chemo-
kine receptor 4 (CXCR4) have been shown to possess unique
properties within the chemokine system. Studies in knockout
animals have demonstrated that apart from being a classical
inflammatory chemokine, SDF-1 is essential for normal embry-
ogenesis. During ontogeny of the hematopoietic system, SDF-1
appears to play a critical role in inducing the migration of
primitive hematopoietic stem and progenitor cells from the
fetal liver to the bone marrow [5, 6]. Targeted disruption of
SDF-1 or CXCR4 is lethal, and embryos show similar pheno-
types in both deficiencies, indicating that SDF-1 interacts
exclusively with CXCR4 and vice versa. Absence of CXCR4 or
SDF-1 is associated with defective cardiogenesis, lympho- and
myelopoiesis, organ vascularization, and development of the
cerebellum [6–9].
In adult mice, the CXCR4/SDF-1 chemotactic axis is in-
volved in the regulation of mobilization of hematopoietic pro-
genitor cells and mature neutrophils from the bone marrow in
response to granulocyte-colony stimulating factor (G-CSF),
which plays a critical role in production and maturation of
neutrophils [10, 11] but is also known to be a potent stimulus
for inducing neutrophil release from the bone marrow [12–14].
The release of immature and mature neutrophils in response to
G-CSF from the bone marrow has been associated with the
inactivation of the SDF-1/CXCR4 chemotactic pathway [15,
16]. Upon treatment with G-CSF, the level of SDF-1 protein in
the bone marrow is significantly decreased [14, 15, 17]. It is
interesting that the degree of neutrophil mobilization in re-
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sponse to G-CSF is correlated with the magnitude of the
decrease in bone marrow SDF-1 [14]. In addition, in mice
reconstituted with CXCR4-deficient bone marrow cells, pre-
mature release of granulocytic precursors was observed [5, 18].
These data suggest that CXCR4 activation by SDF-1 provides
a key retention signal for hematopoietic cells in the bone
marrow.
CXCR4 belongs to the class of G protein-coupled receptors
(GPCRs). Members of a family of seven GPCR kinases (GRKs)
can attenuate the responsiveness of GPCRs [19–21]. Phos-
phorylation of agonist-activated receptors by GRKs induces a
rapid uncoupling of the receptor from G proteins, a process
called homologous desensitization. GRK-mediated phosphory-
lation of the agonist-bound receptor induces uncoupling by
promoting the binding of members of the arrestin family to the
phosphorylated receptor, which then prevents further G protein
activation and enhances receptor internalization [19–21]. The
cellular levels of GRKs and arrestins are thought to be very
important in this process, as this determines the extent of
receptor desensitization and internalization [22, 23].
GRK2, -3, -5, and -6 are particularly highly expressed in
cells of the immune system [24, 25]. Recently, it was demon-
strated that GRK6 is an important regulator of CXCR4 activity
in lymphocytes. T cells genetically deficient in GRK6 dis-
played changes in CXCR4 signaling and SDF-1-induced che-
motactic responses [26]. It is interesting that expression levels
of GRK6 were shown to be altered during differentiation of the
promyelocytic cell line HL-60 toward the neutrophil lineage,
suggesting a functional role for this GRK in regulating GPCR
responsiveness in neutrophils as well [25].
In this study, we used mice with a targeted deletion of the
GRK6 gene to investigate the possible role of GRK6 in regu-
lation of CXCR4-mediated neutrophil chemotaxis in vitro. In
addition, we assessed the effect of GRK6 absence on the
G-CSF-induced rise in circulating neutrophils in vivo.
MATERIALS AND METHODS
Mice
We used GRK6-deficent mice and littermate controls from a mixed C57/Bl6
SVJ/129 background [26, 27]. Animals were genotyped by polymerase chain
reaction and housed in the Central Animal Facility of Utrecht University (The
Netherlands) under specific pathogen-free conditions. The animal committee of
the University Medical Center Utrecht approved all animal experiments.
G-CSF
Pegylated G-CSF (peg-G-CSF), synthesized by coupling recombinant G-CSF
N-terminally to 20 kDa polyethylene glycol, was obtained from Amgen (Thou-
sand Oaks, CA). Peg-G-CSF was administered subcutaneously (s.c.) at a dose
of 15 g in 150 l phosphate-buffered saline (PBS). At different time points,
peripheral blood was obtained via puncture of the orbital plexus or of the heart.
Whole blood cell counts were performed using a Bu¨rker counting chamber, and
leukocyte differentials were performed on May-Gru¨nwald/Giemsa-stained
blood smears.
Isolation of bone marrow cells
Femurs and tibias were cleaned and subsequently crushed in a mortar. A total
bone marrow suspension was obtained and resuspended in RPMI containing
5% fetal calf serum (FCS). The suspension was filtered and subsequently
centrifuged for 5 min at 1200 rpm. Leukocyte differentials of the bone marrow
were performed on May-Gru¨nwald/Giemsa-stained cytospins of total bone
marrow cell suspensions (in RPMI5% FCS). For chemotaxis assays, eryth-
rocytes and most primitive (blast) cells were removed using Percoll gradients
(Amersham Biosciences AB, Uppsala, Sweden). Subsequently, cells were
resuspended in RPMI  0.5% FCS and were counted.
Chemotactic assay
Cell migration was assessed using a Transwell system with 5 m pore filters
(Costar, Cambridge, MA). Before use, the filters were coated overnight at 4°C
with 20 g/ml fibronectin (in PBS). Subsequently, cells were placed in the top
well in a total volume of 100 l and 600 l SDF-1 (R&D Systems, Minneap-
olis, MN), or medium (RPMI 1640 with 0.5% FCS) was added to the lower
chamber. After 2 h incubation at 37°C, cells in the bottom chamber were
collected, and the number of migrated PMN was determined by flow cytometry,
based on forward- and side-scatter characteristics (FACSCalibur, Becton Dick-
inson, San Jose, CA).
Calcium reponse
Bone marrow neutrophils were loaded with Fluo-3 AM (Molecular Probes,
Eugene, OR) and stimulated with SDF-1 in RPMI 1640 supplemented with
0.05% bovine serum albumin (BSA). Changes in mean fluorescence intensity
(MFI) were monitored using a FACSCalibur. Traces represent MFI for 200–
300 cells/s sampled in 500-ms periods.
Colony assay
Bone marrow cells were plated in duplicate at densities of 1  104/ml in
methylcellulose medium supplemented with 30% fetal bovine serum, 1% BSA,
0.1 mM 2-mercaptoethanol, 2 mM L-glutamine, and G-CSF (100 ng/ml).
Colonies (30 cells or more) were counted after 6 days of culture at 37°C.
Data analysis
Data are expressed as mean and SEM and were collected in independent
experiments using three pairs of animals in each experiment. Wild-type (WT)
and knockout samples were analyzed in parallel. Data were analyzed by
Student’s t-test or two-way ANOVA. P  0.05 was considered statistically
significant.
RESULTS
Chemotactic responsiveness of neutrophils
to SDF-1
Using a Transwell chemotaxis assay, we assessed the in vitro
chemotactic response toward SDF-1 (CXCL12) of bone mar-
row-derived polymorphonuclear neutrophils (PMN) from un-
treated WT and GRK6/ animals. No significant difference
was observed in basal motility of PMN (with medium in upper
and lower wells) from WT or GRK6/ animals (Fig. 1). In
addition, the chemokinetic response of WT and GRK6/
PMN to SDF-1 (SDF-1 in upper and lower well) was also
similar. However, the chemotactic response of GRK6/
PMN to SDF-1 (with SDF-1 only in the lower well) was signif-
icantly enhanced, compared with WT cells.
Desensitization of CXCR4
GRKs are known to be involved in homologous receptor de-
sensitization of GPCR, the process that prevents a response of
these receptors to restimulation with the same agonist. It is
known that CXCR4 desensitizes after stimulation with SDF-1
[28]. Moreover, deficient desensitization of GPCR is thought to
result in increased functional effects of the agonist. To get more
insight about the role of GRK6 in desensitization of CXCR4,
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we investigated the role of GRK6 in desensitization of the
calcium response of neutrophils by pre-exposure of cells to
SDF-1. Cells were loaded with Fluo-3 to allow monitoring of
changes in intracellular calcium concentrations and stimulated
with 100 nM SDF-1. The data in Figure 2 show that the
calcium response of GRK6/ and WT neutrophils is similar.
After 5 min stimulation with 100 nM SDF-1, cells were washed
extensively and restimulated with 100 nM SDF-1. As expected,
WT neutrophils do not show an increase in intracellular cal-
cium concentration after restimulation with SDF-1, whereas
these cells do respond to stimulation with another stimulus
(300 nM fMLP; Fig. 2, dotted line). In contrast, GRK6/
neutrophils that had been prestimulated with 100 nM SDF-1
for 5 min do respond with an increase in intracellular calcium
when they are stimulated a second time (Fig. 2, solid line).
These data suggest that desensitization of CXCR4 in neutro-
phils is impaired in the absence of GRK6.
Peg-G-CSF-induced increase in circulating
neutrophils
SDF-1 and its receptor CXCR4 are involved in the mobilization
of bone marrow-derived neutrophils in response to G-CSF.
Therefore, we assessed the G-CSF-induced increase in circu-
lating neutrophils in GRK6/ and WT mice. Blood was
drawn at different time points after a single s.c injection of
peg-G-CSF, and circulating neutrophil numbers were deter-
mined. In WT mice, peg-G-CSF induced a time-dependent
increase in the number of circulating PMN, which peaked at
day 3 after administration and normalized again at day 5 (Fig.
3A). These data are in line with the results obtained by van
Spriel et al. [29] using the same peg-G-CSF. In GRK6/
mice, however, the response to peg-G-CSF was severely im-
paired. At day 3 after peg-G-CSF injection, PMN levels in
peripheral blood from GRK6/ mice were significantly lower
than in WT mice (Fig. 3A). In WT mice, PMN counts were
increased approximately sevenfold, whereas the number of
blood PMN in GRK6/ mice had only doubled. Blood
neutrophil counts in untreated WT and GRK6/ animals
were similar.
Fig. 3. (A) Neutrophil response to peg-G-CSF treatment. Open bars, WT;
solid bars, GRK6/. Mice were given a single s.c. dose of peg-G-CSF (15
g), and the number of blood PMN/ml was analyzed at the indicated times.
Data represent mean SEM. (B) Short-term neutrophil response to peg-G-CSF.
Circulating PMN/ml were determined before and 3 h after s.c. injection of 15
g peg-G-CSF. Data are expressed as percentage increase over basal PMN/ml
and represent mean  SEM. n  5–10 animals per group; *, P  0.05; **, P
 0.01 (Student’s t-test).
Fig. 1. Chemotactic response of bone marrow-derived PMN from WT and
GRK6/ mice. Open bars, WT; solid bars, GRK6/ animals. PMN
chemotaxis was determined in a Transwell assay. Medium alone or increasing
doses of SDF-1 were added to the lower well, and cells were placed in the
upper well in medium for 2 h. Spontaneous cellular motility was determined
with medium in upper and lower wells. To determine the chemokinetic
response (kinesis), 100 ng/ml SDF-1 was added to the upper and the lower
wells. Data represent percentage of cells from the total number used that
reached the lower well. n  5–10 per group; **, P  0.01 (two-way ANOVA).
Fig. 2. Desensitization of the calcium response to SDF-1. Bone marrow-
derived PMN were loaded with Fluo-3, and the change in MFI as an indicator
of changes in intracellular calcium concentration was monitored by flow
cytometry. Basal Fluo-3 fluorescence was recorded for 15 s, and cells were
stimulated with 100 nM SDF-1. The response to SDF-1 was monitored for 60 s.
Cells were kept in the presence of SDF-1 for 5 min, washed extensively on ice,
and resuspended in warm medium, and a second baseline was recorded
followed by resimulation with 100 nM SDF-1. As a control, cells were subse-
quently stimulated with formyl-Met-Leu-Phe (fMLP; 300 nM). Dotted line,
Control; solid line, GRK6/ PMN. Data are from one representative animal
out of three in each group.
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Early neutrophil mobilization induced by
peg-G-CSF
The G-CSF-induced rise in PMN levels at day 3 reflects
neutrophil production as well as mobilization. To discriminate
between these two processes, circulating neutrophil numbers
were assessed 3 h after s.c. injection of peg-G-CSF (Fig. 3B).
As this time period is too short for G-CSF to induce generation
of neutrophils, the acute response is thought to primarily reflect
neutrophil mobilization from the bone marrow into the blood
[12, 30]. In WT mice, 3 h after peg-G-CSF treatment, the
number of blood PMN was increased by115% over baseline.
However, the neutrophil response in GRK6/ animals was
significantly reduced, as compared with WT mice. PMN levels
increased by only 38% in the GRK6/ animals, suggest-
ing that G-CSF-induced neutrophil mobilization is impaired in
the absence of GRK6 (Fig. 3B).
Cellular composition of the bone marrow before
and after GCSF treatment
The observation that the peg-G-CSF-induced increase in blood
PMN levels at day 3 is impaired in the absence of GRK6 might
result from impaired mobilization but could also result from
reduced neutrophil production or residence in the bone mar-
row. Therefore, we analyzed the cellular composition of bone
marrow from WT and GRK6/ animals. Under basal condi-
tions, no differences were observed in percentages of immature
myeloid cells, eosinophils, monocytes/macrophages, and lym-
phocytes between WT and GRK6/ mice (data not shown).
In addition, percentages of cells belonging to the granulocytic
lineage, such as band neutrophils and polymorphonuclear neu-
trophils, did not differ between WT and GRK6/ bone
marrow either (data not shown). Thus, the reduced ability of
G-CSF to mobilize bone marrow neutrophils does not result
from a lower resident neutrophil population in the bone marrow
of GRK6/ animals.
Three days after peg-G-CSF injection, the percentage of
neutrophils in the bone marrow had significantly and equally
increased in WT and GRK6/ mice. No differences were
observed in the cellular composition of bone marrow from
GRK6/ mice and WT animals, suggesting that the G-CSF-
induced production of neutrophils in the bone marrow in
GRK6/ mice is not impaired (data not shown). To further
assess the possible role of GRK6 in the G-CSF-induced pro-
duction of PMN, we determined the in vitro response to G-CSF
in colony assays. G-CSF-induced colony formation by bone
marrow progenitor cells from WT and GRK6/ mice was
analyzed. As is shown in Figure 4, the number of colonies
obtained after stimulation with G-CSF did not differ between
GRK6/ and WT cultures.
Assessment of neutrophil apoptosis
Increased neutrophil apoptosis might also explain the low
numbers of circulating neutrophils in GRK6/ animals in
response to G-CSF. To get more insight into the rate of apo-
ptosis, bone marrow-derived neutrophils were obtained at day
3 after peg-G-CSF injection, and flow cytometric analysis of
annexin-V and propidium iodine-stained samples was per-
formed. As is shown in Figure 5, no difference in the per-
centage of annexin-Vpos/propidium iodineneg cells was ob-
served between GRK6/ and WT animals. Moreover, when
cells were cultured without growth factors for 24 and 48 h, the
percentage of annexin-V-positive cells was equally increased
in WT and GRK6/ cell cultures, suggesting that there is no
alteration in survival of neutrophils in the absence of GRK6
(Fig. 5).
Fig. 4. Colony formation by bone marrow progenitors from WT and
GRK6/ mice. Colonies were grown in the presence of 100 ng/ml G-CSF.
Data represent mean colony numbers  SEM. n  5 per group.
Fig. 5. Assessment of neutrophil apoptosis. Neutrophils were isolated from
bone marrow 3 days after injection of peg-G-CSF. Apoptosis was assessed by
flow cytometric analysis of cells stained with fluorescein isothiocyanate (FITC)-
labeled annexin-V and propidium iodine. In addition, the percentage of
apoptotic cells was analyzed after a culture period of 24 or 48 h without growth
factors. Percentage of positive cells is indicated in the dot plot. Four animals
per group were analyzed. Shown are representative dot plots of one WT and one
GRK6/ animal.
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Chemotactic responsiveness of neutrophils to
SDF-1 after treatment with peg-G-CSF
To assess whether the difference in chemotactic responsive-
ness between WT and GRK6/ PMN is maintained after
peg-G-CSF treatment, we also analyzed SDF-1-induced migra-
tion of PMN isolated from the bone marrow 3 days after
administration of peg-G-CSF. GRK6/ PMN derived from
peg-G-CSF-treated bone marrow showed an increased chemo-
tactic response to SDF-1, as compared with WT cells (Fig. 6).
Again, analysis of basal motility as well as the chemokinetic
response to SDF-1 revealed no differences between GRK6/
and WT cells (Fig. 6).
DISCUSSION
In this paper, we demonstrate that the G-CSF-induced increase
in circulating neutrophils is significantly impaired in the ab-
sence of GRK6. G-CSF has been characterized as the principal
hematopoietic cytokine regulating granulopoiesis. In addition,
G-CSF is well known for its ability to induce neutrophil release
from the bone marrow. Administration of peg-G-CSF induces
an immediate neutrophilia, which peaks at 3 h after injection
and results from mobilization of cells from bone marrow to
blood. Subsequently, a second increase in blood neutrophils
can be observed at day 3 after injection, which is dependent on
neutrophil production in the bone marrow. We demonstrate
that the early/acute neutrophil response 3 h after administra-
tion of peg-G-CSF is reduced in GRK6/ animals, suggest-
ing that neutrophil mobilization from the bone marrow is im-
paired. In addition, peg-G-CSF treatment resulted in little or
no increase in circulating neutrophils at day 3 after adminis-
tration.
The impaired neutrophil response to G-CSF in GRK6/
mice might be the result of altered G-CSF receptor (G-CSFR)
signaling in the absence of GRK6. Growth factor receptors
such as the G-CSFR do not belong to the GPCR family, which
are substrates for desensitization by GRKs. However, previous
studies have indicated that GRKs might affect signaling in
response to growth factor receptors as well. For instance,
overexpression of GRK2 has been shown to affect mitogenic
signaling and proliferation of smooth muscle cells and osteo-
blastic cells in response to platelet-derived growth factor and
insulin-like growth factor-1, respectively [31, 32].
G-CSFR signals are essential for proliferation, maturation,
and survival of neutrophils in the bone marrow, as well as for
the maintenance of homeostatic/steady-state levels of neutro-
phils in the blood [11, 14, 33, 34]. Thus, if G-CSFR signaling
is altered in the absence of GRK6, we would expect to observe
differences in steady-state blood PMN levels between WT and
GRK6/ animals. However, basal PMN counts were equal in
WT and GRK6/ mice. In addition, analysis of bone marrow
cellular composition before and after G-CSF treatment re-
vealed no differences between WT and GRK6/ animals.
Notably, percentages of bone marrow neutrophils had in-
creased equally in both animals. Furthermore, G-CSF-induced
colony formation by WT and GRK6/ bone marrow progen-
itors did not differ, suggesting that neutrophil production in
response to G-CSFR signals is normal. Moreover, there was no
difference in percentages of apoptotic bone marrow cells as
well as in cell survival between WT and GRK6/ mice.
Finally, Semerad et al. [14] demonstrated that in mixed chi-
meras reconstituted with WT and G-CSFR mutant bone marrow
cells, G-CSFR-deficient and WT neutrophils were mobilized
equally by G-CSF [14]. This finding indicates that neutrophil
mobilization is not dependent on G-CSFR expression on neu-
trophils, suggesting that altered signaling of this receptor on
GRK6/ neutrophils is not the cause of the observed, im-
paired mobilization of these cells in response to G-CSF. Taken
together, the data argue against a role of altered G-CSFR
signaling in the observed deficient neutrophil response to
G-CSF in GRK6/ animals.
It is thought that G-CSF induces neutrophil mobilization
indirectly through the generation of trans-acting signals. The
nature of these secondary signals is still largely unknown.
However, there is accumulating evidence suggesting that pro-
teolytic disruption of the CXCR4/SDF-1 signaling pathway
may represent an important mechanism regulating mobilization
of neutrophils in response to G-CSF [14–17]. It is thought that
SDF-1/CXCR4 signaling represents a key retention signal for
neutrophils/hematopoietic progenitors in the bone marrow and
that desensitization of CXCR4 may be an important mechanism
in inducing cell mobilization from the bone marrow in response
to G-CSF treatment. In line with this hypothesis, we observed
an increased sensitivity of bone marrow-derived neutrophils
from GRK6/ animals to migrate toward SDF-1. In naive as
well as in G-CSF-treated animals, we demonstrated enhanced
SDF-1-induced chemotaxis of GRK6/ neutrophils as com-
pared with WT cells. Based on these data, we propose that
impaired desensitization of CXCR4 in the absence of GRK6
causes the observed, impaired neutrophil mobilization in
GRK6/ mice. Increased sensitivity of the CXCR4/SDF-1
signaling pathway might promote increased retention of neu-
Fig. 6. Motility, SDF-1-induced chemotaxis, and SDF-1-induced chemoki-
nesis (kinesis) of PMN from G-CSF-treated WT and GRK6/ mice. Bone
marrow-derived PMN were obtained 3 days after s.c. injection of 15 g
peg-G-CSF. Chemotaxis and chemokinesis were assessed in response to 100
ng/ml SDF-1. Open bars, WT; solid bars, GRK6/ animals. Data represent
percentage of cells from the total number used that reached the lower well. n
6 per group; **, P  0.01 (two-way ANOVA).
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trophils in the bone marrow, resulting in little or no increase in
circulating neutrophils in response to G-CSF.
Our present results, showing that desensitization of the
calcium response to stimulation with SDF-1 is impaired in
GRK6/ neutrophils, and the study by Fong et al. [26],
showing increased SDF-1-induced GTPase activity in
GRK6/ lymphocytes, are consistent with the hypothesis
that GRK6 is required for desensitization of CXCR4, presum-
ably via agonist-induced phosphorylation of the receptor. It is
important to realize, however, that CXCR4 has not yet been
identified as a substrate for phosphorylation by GRK6.
Surprisingly, in contrast to neutrophils, chemotaxis of T and
B cells toward SDF-1 is inhibited in the absence of GRK6 [26],
whereas we show here that the chemotactic response of neu-
trophils toward SDF-1 is increased. We cannot exclude that the
difference in chemotactic activity between PMN and T/B cells
reflects differences in cell type-specific characteristics of the
CXCR4 or the way these distinct cells respond to CXCR4
activation. However, it seems more likely that the differences
in SDF-1-induced chemotaxis between PMN and T/B cells are
a result of differences in cell type-specific mechanisms of
migration that are affected by GRK6. Indeed, it has been
suggested that T cells and PMN use different mechanisms to
migrate; T lymphocytes increase locomotion by reducing the
duration of migration breaks, and PMN migrate by reducing
the frequency of migration breaks [35]. In this respect, it is
of interest that we also have data showing increased migra-
tion of GRK6/ PMN toward the chemoattractant leukotri-
ene B4 [50].
Retention of neutrophils in the bone marrow is controlled by
adhesive interactions involving vascular cell adhesion mole-
cule 1 (VCAM-1), which is expressed by stromal cells, and the
integrin very late antigen 4 (VLA-4), which is expressed on
neutrophils [36–39]. Inhibition of the interaction between
VCAM-1 and VLA-4 by infusion of anti-VCAM-1 or anti-
VLA-4 was shown to be sufficient to promote mobilization in
vivo [37, 40–42]. It is interesting that SDF-1 was observed to
stimulate VLA-4-dependent engraftment of immature progen-
itor cells in nonobese diabetic/severe combined immunodefi-
ciency mice [43] and to promote VLA-4-mediated adhesion of
bone marrow cells to fibronectin, VCAM-1, and bone marrow
stroma [44], suggesting that CXCR4 signaling is involved in
regulation of integrin function. Altered modulation of VLA-4-
mediated adhesion of neutrophils as a result of altered CXCR4
signaling could thus represent an underlying mechanism for
the observed, impaired mobilization of neutrophils in
GRK6/ mice.
Release of neutrophils from the bone marrow in response to
G-CSF has been associated with proteolytic degradation of
SDF-1 by serine proteases [17], leading to disruption of
CXCR4/SDF-1 interactions [45–47]. In addition, these serine
proteases were shown to inactivate the VCAM-1 [48, 49]. It can
therefore not be excluded that the impaired neutrophil mobi-
lization in response to G-CSF is the consequence of impaired
proteolytic degradation of SDF-1 or VCAM-1. However, the
possible role of GRK6 in regulation of protease activity is
unknown.
In conclusion, we demonstrate that the increase in circulat-
ing PMN in response to peg-G-CSF is significantly impaired in
the absence of GRK6, suggesting a crucial role for this kinase
in regulation of neutrophil mobilization via regulation of re-
sponsiveness of GPCRs, which are controlled by GRK6, such
as CXCR4.
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